Which action is most appropriate in a suspected malignant hyperthermia crisis with severe hypercapnia?

Which action is most appropriate in a suspected malignant hyperthermia crisis with severe hypercapnia?

• A. Administer more vecuronium
• B. Administer bicarbonate
• C. Administer succinylcholine
• D. Administer dantrolene

Answer: (D)

In a suspected malignant hyperthermia crisis, the immediate action is to administer dantrolene, the specific antidote that halts the abnormal calcium release driving the crisis. Malignant hyperthermia triggers a sudden, uncontrolled release of calcium from the skeletal muscle’s sarcoplasmic reticulum via the ryanodine receptor, causing sustained muscle contraction, excessive metabolism, and a rapid rise in CO2 production (hypercapnia), heat, and acidosis. Dantrolene works by binding to the ryanodine receptor and preventing calcium release, which rapidly reduces muscle rigidity and metabolic heat production, helping to reverse the hypercapnia and other life-threatening derangements. Start with an initial dose of IV dantrolene (2.5 mg/kg) and repeat as needed up to a total dose guided by response, all while stopping triggering agents, providing 100% oxygen, cooling measures, and treating electrolyte and acid-base disturbances. Additional vecuronium would not address the underlying calcium dysregulation and may not help the crisis. Succinylcholine is a triggering agent for malignant hyperthermia and would worsen the situation. Bicarbonate can help correct acidosis but does not stop the ongoing calcium-driven crisis, making it supportive rather than curative in this context.

In a suspected malignant hyperthermia crisis, the immediate action is to administer dantrolene, the specific antidote that halts the abnormal calcium release driving the crisis. Malignant hyperthermia triggers a sudden, uncontrolled release of calcium from the skeletal muscle’s sarcoplasmic reticulum via the ryanodine receptor, causing sustained muscle contraction, excessive metabolism, and a rapid rise in CO2 production (hypercapnia), heat, and acidosis. Dantrolene works by binding to the ryanodine receptor and preventing calcium release, which rapidly reduces muscle rigidity and metabolic heat production, helping to reverse the hypercapnia and other life-threatening derangements. Start with an initial dose of IV dantrolene (2.5 mg/kg) and repeat as needed up to a total dose guided by response, all while stopping triggering agents, providing 100% oxygen, cooling measures, and treating electrolyte and acid-base disturbances.

Additional vecuronium would not address the underlying calcium dysregulation and may not help the crisis. Succinylcholine is a triggering agent for malignant hyperthermia and would worsen the situation. Bicarbonate can help correct acidosis but does not stop the ongoing calcium-driven crisis, making it supportive rather than curative in this context.